Thoracic Oncology Group Of Australasia (TOGA)
Conversations in Lung Cancer Research
Welcome to Conversations in Lung Cancer Research, presented by TOGA, your go-to podcast for in-depth insights into lung cancer. Tune in for conversations with leading experts, inspiring stories, and the latest updates on clinical trials. Stay informed and empowered in the fight against lung cancer.
Be sure to visit the podcast's website and support the creator: toga-podcast.simplecast.com
Author
Thoracic Oncology Group Of Australasia (TOGA)
Category
Podcast website
Latest episode
Oct 29, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
2020 Wrap: Remarkable Progress In Diagnosing & Treating Lung Cancer 18.11.2020 27:40
Remarkable advances in screening, diagnosing and treating lung cancer are discussed in this Podcast. Associate Professor Nick Pavlakis , Medical Oncologists from Royal North Shore Hospital Sydney and Dr Emily Stone , Respiratory Physician from St Vincent’s Hospital Sydney join TOGA for a conversation about public health measures to ensure the survival increase we are seeing for patients with lung...
Redefining Survival In Lung Cancer: Meet Alexandra 10.11.2020 21:51
Lung cancer is the leading cause of cancer related deaths in Australia, and lung cancer in never smokers is still the seventh leading cause of death. Lung cancer kills more women every year than breast, ovarian and uterine cancers combined even though many seem to think that the only cancer women ever get is breast cancer! More young women are being diagnosed every year who have never smoked – aro...
Improving Survival In Oncogene Driven Lung Cancer 10.11.2020 30:16
Join us for a conversation with internationally recognized Medical Oncologists and researchers, Professor Ben Solomon & Associate Professor Tom John as they discuss the increased survival benefits for patients with oncogene driven lung cancer and how novel treatments are contributing. Oncogenes discussed include EGFR & osimertinib; ALK & brigatinib, alectinib, lorlatinib; ROS1 & crizotinib, entrec...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.